Laurus Labs — Re-igniting Pharma Strength 💊

climbed 1.7% to ₹1,003, extending its uptrend within the pharma pack. The stock continues its steady ascent with improving earnings visibility and strong formulation exports. Technical View: Price rebounded from ₹960 support, holding above 14-EMA with RSI at 63.2, signaling healthy bullish momentum. Sustaining above ₹995 may lead to next leg toward ₹1,050–₹1,080; support seen near ₹970. Trend bias: Positive; mild consolidation possible before continuation. Fundamental View: Strong outlook in CDMO, APIs, and oncology formulations. Revenue diversification into non-ARV portfolio improving stability. Margins expected to expand with normalization of input costs and operating leverage. Brokerages maintain a Buy stance with medium-term targets near ₹1,100+.